Caribou Biosciences Investors
Caribou Biosciences is a prominent venture capital fund based in Berkeley, California, founded in 2011 The firm specializes in investing in innovative biotechnologies, particularly those related to gene editing and synthetic biology With a significant investment scale of approximately $304 million, Caribou Biosciences actively supports early-stage companies that are poised to transform the life sciences sector The funds strategic focus on groundbreaking research and development positions it as a key player in advancing scientific innovation
Investors
Founded Date:
2011
Last Funding Type:
Series C
Headquarters:
USA
Investors Number:
28
Technology:
Others
Employee Number:
101-250
Industry:
FemTech
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021
Number Of Exists:
1
Funding Status:
Late Stage Venture
Investor Type:
Venture Capital Funds
Investment Stage:
N/A
Total Funding:
167549904